Clinical Implications of Epigenetic Dysregulation in Perinatal Hypoxic-Ischemic Brain Damage

Area of Science:

• Neuroscience
• Epigenetics
• Perinatal Medicine

Background:

• Perinatal hypoxic-ischemic events lead to stillbirth and neonatal neurological issues.
• Brain hypoxia triggers pathological processes contributing to long-term neurological dysfunction.
• Epigenetic alterations are increasingly recognized in hypoxic-ischemic encephalopathy (HIE).

Purpose of the Study:

• To summarize the current understanding of epigenetic mechanisms in hypoxic-ischemic brain damage.
• To explore the clinical implications of epigenetic dysregulation in perinatal HIE.
• To highlight potential diagnostic, prognostic, and therapeutic applications.

Main Methods:

• Review of recent studies on epigenetic modifications in HIE.
• Analysis of DNA (de)methylation, histone modifications, and non-coding RNAs in HI brain injury.
• Synthesis of molecular pathology and clinical relevance of epigenetic changes.

Main Results:

• Epigenetic dysregulation, including DNA methylation and non-coding RNAs, plays a crucial role in HIE.
• These epigenetic changes contribute to lasting disruptions in gene expression and neurological dysfunction.
• Understanding these mechanisms is vital for advancing clinical interventions.

Conclusions:

• Epigenetic mechanisms are central to the molecular pathology of HI brain damage.
• Targeting epigenetic modifications offers potential for novel diagnostic and therapeutic strategies in perinatal HIE.
• Further research into epigenetic dysregulation can improve outcomes for affected neonates.